Aducanumab

Elana Gotkine TUESDAY, Dec. 6, 2022 (HealthDay News) -- The U.S. Food and Drug Administration decision to approve aducanumab may have negatively impacted willingness to participate in preclinical…

Atlanta, GA., Bismarck, ND., Burlington, MA., Denver, CO., Hoffman Estates, IL, NY, NY, Rockport, ME, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Down Syndrome Affiliates in Action (DSAIA), GiGi’s Playhouse Down Syndrome Achievement Centers,…

CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) announced today an update on the ongoing review of the Marketing Authorization Application for aducanumab 100 mg/mL…

A man treated with the recently approved Alzheimer's drug aducanumab (Aduhelm) had six amyloid-related imaging abnormality (ARIA) episodes,…

Note that some links may require registration or subscription. NBC News reports that the FDA will update the emergency use authorizations for…

Three opinion pieces published Wednesday in the New England Journal of Medicine may end up in business school classes as a case study in how one…

Not all physicians who treat Alzheimer's disease will prescribe the new Alzheimer's drug aducanumab (Aduhelm) -- major hospital systems like the Cleveland Clinic and Mount Sinai in…

https://www.youtube.com/watch?v=8Rok-9DqdOM ZDoggMD and Vinay Prasad, MD, MPH, analyze the evidence so far on ivermectin for COVID-19 and aducanumab (Aduhelm) for Alzheimer's…

Just a month after it gave the new Alzheimer's drug aducanumab (Aduhelm) the green light, the FDA decided to change the label. The agency…

SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, is pleased to have supported Biogen with its efforts to obtain FDA accelerated…